Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | CES2 | O00748 | 1/20 | 0.32 |
| ▸ | CES1 | P23141 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL304423 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10CES2CES1THRB | |
| SCHEMBL3617593 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10CES2CES1THRB | |
| SCHEMBL105254 | 1.00 | — | — | |
| SCHEMBL3619231 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10CES2CES1THRB | |
| SCHEMBL3627050 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10CES2CES1THRB | |
| SCHEMBL3620835 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10CES2CES1THRB | |
| SCHEMBL15373185 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10CES2CES1THRB | |
| SCHEMBL42570 | 1.00 | — | — | |
| SCHEMBL103932 | 1.00 | — | — | |
| SCHEMBL3622611 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10CES2CES1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9422498-B2 | Low viscosity, low volatility lubricating oil basestocks | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2016-08-23 | — | — | US | claimed |
| US-9422502-B2 | Low viscosity, low volatility lubricating oil basestocks | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2016-08-23 | — | — | US | claimed |
| WO-2015153022-A1 | LOW VISCOSITY, LOW VOLATILITY LUBRICATING OIL BASESTOCKS | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2015-10-08 | — | — | WO | claimed |
| WO-2015153023-A1 | LOW VISCOSITY, LOW VOLATILITY LUBRICATING OIL BASESTOCKS | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2015-10-08 | — | — | WO | claimed |
| WO-2015153021-A2 | LOW VISCOSITY, LOW VOLATILITY LUBRICATING BASESTOCKS | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2015-10-08 | — | — | WO | claimed |
| US-20150275117-A1 | LOW VISCOSITY, LOW VOLATILITY LUBRICATING OIL BASESTOCKS | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2015-10-01 | — | — | US | claimed |
| US-20150275128-A1 | LOW VISCOSITY, LOW VOLATILITY LUBRICATING OIL BASESTOCKS | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2015-10-01 | — | — | US | claimed |
| US-20150275129-A1 | LOW VISCOSITY, LOW VOLATILITY LUBRICATING OIL BASESTOCKS | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2015-10-01 | — | — | US | claimed |
| EP-4663693-A1 | METHOD FOR DECOMPOSING COMPOUND | National Institute Of Advanced Industrial Science and Technology (JP) | 2025-12-17 | — | — | EP | disclosed |
| WO-2024166919-A1 | METHOD FOR DECOMPOSING COMPOUND | 国立研究開発法人産業技術総合研究所 | 2024-08-15 | — | — | WO | disclosed |
| CN-112279864-B | Difunctional coumarin oxime ester compound and preparation and application thereof | 湖北固润科技股份有限公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-111302926-B | Beta-diketone cerium (IV) compound and preparation and application thereof | 湖北固润科技股份有限公司 | 2024-04-02 | — | — | CN | disclosed |
| WO-2024041569-A1 | ACYLOXYPHOSPHINE OXIME ESTER COMPOUND SUITABLE FOR DEEP CURING OF UV-VIS LED LIGHT SOURCES, METHOD FOR PREPARING SAME, AND USE THEREOF | 湖北固润科技股份有限公司 | 2024-02-29 | — | — | WO | disclosed |
| CN-116806825-A | Antimicrobial mixture | 西姆莱斯股份公司 | 2023-09-29 | — | — | CN | disclosed |
| WO-2001034127-A1 | PREVENTION OF PLAQUE RUPTURE BY ACAT INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2001-05-17 | — | — | WO | disclosed |
| EP-1043327-A1 | PHOSPHONOCEPHEM DERIVATIVES, PROCESS FOR THE PREPARATION OF THE SAME, AND USE THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2000-10-11 | — | — | EP | disclosed |
| US-5948774-A | EXCELLENT ANTIBACTERIAL ACTIVITIES ON A BROAD RANGE OF GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA, ESPECIALLY STAPHYLOCOCCUS AUREUS AND METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1999-09-07 | — | — | US | disclosed |
| EP-0828744-A1 | CEPHEM COMPOUNDS, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 1998-03-18 | — | — | EP | disclosed |
| WO-1996038451-A1 | CEPHEM COMPOUNDS, THEIR PRODUCTION AND USE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-12-05 | — | — | WO | disclosed |
| US-3994979-A | FROM S AND MERCAPTIDE OBTAINED FROM REACTION OF THIOL WITH 1A HYDROXIDE | PHILLIPS PETROLEUM COMPANY (US) | 1976-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150275117-A1 | LOW VISCOSITY, LOW VOLATILITY LUBRICATING OIL BASESTOCKS | ATXN10, KCNK10, F12 | ALDH1A1 4187/4885HSD17B10 1504/4885CES2 4181/4885 |
| US-20150275128-A1 | LOW VISCOSITY, LOW VOLATILITY LUBRICATING OIL BASESTOCKS | F12, OR10J3, ATXN10 | ALDH1A1 4094/4885HSD17B10 1842/4885CES2 4071/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.